Irinotecan AqVida 20 mg/ml concentrate for solution for infusion

Filling Size: 0 mg/3 ml

* Products that are subject to current patent protection are not offered in countries in which sale constitutes a patent infringement.

25 mg, 50 mg Tablets Immunosuppressant

20 mg, 80 mg, 140 mg, 160 mg vial Indications: Treatment of breast cancer, special form of lung cancer, prostate cancer, gastric cancer and head or neck cancer

10 mg, 20 mg, 50 mg, 100 mg, 200 mg vialIndications: Treatment of breast cancer, advanced ovarian cancer, stomach cancer, small cell lung cancer, bladder cancer

200 mg, 1 g, 2 g vial Indications: Treatment of NSCLC, pancreatic cancer, bladder cancer, breast cancer

100 mg, 200 mg, 400 mg capsuleIndications: Treatment of chronic myeloid leukaemia, GIST * Products protected by valid patents are not offered in countries where the sale constitutes a patent infringement.

75 mcg, 150 mcg, 300 mcg, 480 mcg vial Indications: Treatment of neutropenia, e.g. after a chemotherapy, severe chronic neutropenia or neutropenia in patients with HIV infections

50 mg, 100 mg, 200 mg vialIndications: Treatment of advanced colorectal cancer

30 mg, 100 mg, 150 mg, 300 mg vial Indications: Treatment of ovarian cancer, breast cancer, advanced NSCLC, AIDS-related Kaposi‘s sarcoma

100 mg, 500 mg, 1 g vialIndication: Treatment of NSCLC

* Products protected by valid patents are not offered in countries where the sale constitutes a patent infringement.

12.5 mg, 25 mg, 37.5 mg, 50 mg CapsuleIndications: Treatment of mRCC, GIST * Products protected by valid patents are not offered in countries where the sale constitutes a patent infringement.

Filling Sizes: 100 mg; 150 mg